Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- American College of Cardiology
- Abbott Vascular
- Medtronic Inc
- Saskatchewan Health Research Foundation
This publication has 30 references indexed in Scilit:
- Management of Acute Myocardial Infarction During the COVID-19 PandemicJACC, 2020
- North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implicationsAmerican Heart Journal, 2020
- Impact of COVID‐19 pandemic on STEMI care: An expanded analysis from the United StatesCatheterization and Cardiovascular Interventions, 2020
- ST-Elevation Myocardial Infarction in Patients With COVID-19Circulation, 2020
- ST-Segment Elevation in Patients with Covid-19 — A Case SeriesNew England Journal of Medicine, 2020
- Reperfusion of ST-Segment–Elevation Myocardial Infarction in the COVID-19 EraCirculation, 2020
- Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 PandemicJACC, 2020
- A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial InfarctionCirculation, 2007
- Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United StatesCirculation, 2006
- TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at PresentationCirculation, 2000